|
Vista Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
51.89 Cr.
|
P/BV
|
1.14
|
Book Value (Rs.)
|
7.38
|
|
52 Week High/Low (Rs.)
|
13/8
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.79 | -1.03 | -1.54 | -0.24 | -0.54 |
| Diluted EPS (Rs.) | -0.79 | -1.03 | -0.90 | -0.24 | -0.54 |
| Cash EPS (Rs.) | -0.63 | -0.80 | -1.34 | -0.05 | -0.31 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 7.38 | 8.58 | 9.77 | 9.64 | 8.93 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 7.38 | 8.58 | 9.77 | 9.64 | 8.93 |
| Revenue From Operations / Share (Rs.) | 1.64 | 2.18 | 0.26 | 0.10 | 0.34 |
| PBDIT / Share (Rs.) | -0.58 | -0.68 | -1.08 | -0.28 | -0.38 |
| PBIT / Share (Rs.) | -0.70 | -0.83 | -1.24 | -0.45 | -0.58 |
| PBT / Share (Rs.) | -0.85 | -1.10 | -1.56 | -0.69 | -1.00 |
| Net Profit / Share (Rs.) | -0.75 | -0.95 | -1.51 | -0.22 | -0.51 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -35.61 | -31.47 | -403.02 | -264.79 | -111.43 |
| PBIT Margin (%) | -42.93 | -38.46 | -464.56 | -420.95 | -168.89 |
| PBT Margin (%) | -52.50 | -50.32 | -585.46 | -648.98 | -291.20 |
| Net Profit Margin (%) | -46.14 | -43.85 | -564.11 | -210.82 | -148.86 |
| Return on Networth / Equity (%) | -10.23 | -11.15 | -15.42 | -2.34 | -5.73 |
| Return on Capital Employeed (%) | -9.02 | -9.10 | -11.11 | -3.70 | -5.14 |
| Return On Assets (%) | -7.71 | -7.78 | -10.10 | -1.49 | -3.70 |
| Long Term Debt / Equity (X) | 0.05 | 0.07 | 0.14 | 0.26 | 0.26 |
| Total Debt / Equity (X) | 0.16 | 0.19 | 0.27 | 0.35 | 0.45 |
| Asset Turnover Ratio (%) | 0.17 | 0.18 | 0.01 | 0.01 | 0.02 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.19 | 1.61 | 1.69 | 1.43 | 1.65 |
| Quick Ratio (X) | 0.52 | 1.15 | 1.14 | 0.56 | 0.60 |
| Inventory Turnover Ratio (X) | 1.34 | 1.23 | 0.33 | 0.03 | 0.07 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -3.72 | -2.65 | -3.33 | -1.16 | -0.91 |
| Interest Coverage Ratio (Post Tax) (%) | -3.82 | -2.70 | -3.67 | 0.07 | -0.21 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 72.78 | 58.15 | 41.15 | 46.40 | 48.10 |
| EV / Net Operating Revenue (X) | 7.22 | 5.65 | 41.00 | 117.60 | 37.98 |
| EV / EBITDA (X) | -20.29 | -17.96 | -10.17 | -44.41 | -34.08 |
| MarketCap / Net Operating Revenue (X) | 6.56 | 4.89 | 31.28 | 85.97 | 26.26 |
| Price / BV (X) | 1.46 | 1.24 | 0.85 | 0.95 | 1.01 |
| Price / Net Operating Revenue (X) | 6.56 | 4.89 | 31.29 | 86.01 | 26.28 |
| EarningsYield | -0.07 | -0.08 | -0.18 | -0.02 | -0.05 |
